GlassScriptPhysician profile
Ni Jui J Liang
NPI 1457558413
$3,959.09
in general payments reported to CMS, 2019-2025
28 companies · $2,047 in 2025
The $2,047 reported for 2025 was more than what 85% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $417 · 2020: $276 · 2021: $137 · 2022: $400 · 2023: $409 · 2024: $273 · 2025: $2,047.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,377 · Long Term Medical Supply Or Device Loan: $1,351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,377.32 |
| Long Term Medical Supply Or Device Loan | $1,351.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,703.18 | 2019-2025 | Cytal, Micromatrix, Integra |
| Allergan, INC. | $401.82 | 2019-2022 | |
| Tela Bio, INC. | $327.23 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Abbvie INC. | $209.87 | 2023-2025 | |
| Mentor Worldwide LLC | $161.69 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Artoura Breast Tissue Expander |
| Ethicon US, LLC | $136.60 | 2019-2025 | Stratafix, Dermabond, Vistaseal |
| Axogen | $134.46 | 2019-2025 | Avance Nerve Graft |
| Polynovo North America LLC | $104.96 | 2020-2025 | Novosorb Btm |
| Davol INC. | $81.43 | 2022 | |
| Sientra, INC. | $68.50 | 2020 | |
| Biom'Up France Sas | $60.50 | 2020-2021 | |
| Baxter Healthcare | $58.80 | 2022-2023 | Artiss |
| Kci USA, INC. | $55.31 | 2019-2021 | |
| Kerecis Limited | $47.17 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Stryker Corporation | $46.00 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $40.85 | 2024 | Prevena Restor Bellaform, V.A.C. Simplace, Activ.A.C. |
| Revance Therapeutics, INC. | $38.77 | 2024 | Daxxify |
| Motiva USA, LLC | $35.36 | 2025 | |
| Access Pro Medical, LLC | $34.06 | 2025 | Matriderm |
| Tepha INC | $32.96 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $31.18 | 2025 | |
| Acell, INC. | $27.97 | 2020 | |
| Coopersurgical, INC. | $26.63 | 2024 | Summit Doppler |
| Pacira Pharmaceuticals Incorporated | $23.96 | 2022 | |
| Biotissue Holdings INC. | $22.71 | 2023 | |
| Tei Biosciences INC | $22.21 | 2019 | |
| Smith+Nephew, INC. | $14.91 | 2025 | Collagenase Santyl |
| Reprise Biomedical, INC. | $10.00 | 2024 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ni Jui Liang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.